RENX.L LSE
Renalytix Plc
1W: -5.5%
1M: +40.0%
3M: +115.2%
YTD: +3.8%
1Y: -0.7%
3Y: -95.2%
5Y: -99.3%
£5.81 ($0.08)
-0.19 (-3.20%)
Weekly Expected Move ±17.2%
£4
£5
£6
£7
£8
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$3M
+31.1% ▲
Gross Profit
$1M
+669.2% ▲
Operating Income
-$17M
+41.9% ▲
Net Income
-$20M
+39.0% ▲
EPS (Diluted)
$-0.21
+32.3% ▲
EBITDA
-$21M
+25.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1M | $3M | $3M | $2M | $3M |
| YoY Growth | +0.0% | +99.2% | +14.6% | -32.7% | +31.1% |
| Cost of Revenue | $804K | $2M | $3M | $2M | $2M |
| Gross Profit | $687K | $918K | $701K | $156K | $1M |
| Gross Margin | 46.1% | 30.9% | 20.6% | 6.8% | 40.0% |
| R&D Expenses | $10M | $15M | $14M | $9M | $900K |
| SG&A Expenses | $8M | $13M | $29M | $20M | $5M |
| Operating Expenses | $33M | $58M | $43M | $30M | $18M |
| Operating Income | -$32M | -$53M | -$42M | -$30M | -$17M |
| Operating Margin | -2140.6% | -1790.7% | -1244.6% | -1293.5% | -573.3% |
| Interest Expense | $3K | $2K | $0 | $0 | $500K |
| Income Before Tax | -$35M | -$45M | -$46M | -$33M | -$22M |
| Tax Expense | -$5M | $25K | $2K | $4K | -$1M |
| Net Income | -$35M | -$45M | -$46M | -$33M | -$20M |
| Net Margin | -2329.0% | -1524.4% | -1340.2% | -1461.6% | -680.0% |
| EPS (Diluted) | $-0.43 | $-0.67 | $-0.55 | $-0.31 | $-0.21 |
| EBITDA | -$33M | -$53M | -$42M | -$29M | -$21M |
| Shares Outstanding | 71M | 74M | 82M | 108M | 97M |